$20.3M
1-10
Clinical stage cell therapy platform company developing first-in-class therapeutics for ALS and other neurodegenerative diseases
City Rank
Share
2nd
In Houston
out of 2 exits
National Rank
Share
120th
In United States
out of 194 exits
Regional Rank
Share
125th
In North America
out of 204 exits
City Rank
Share
2nd
In Houston
out of 2 exits
National Rank
Share
75th
In United States
out of 124 exits
Regional Rank
Share
78th
In North America
out of 129 exits
Exit Explorer
rankings by:
Not enough data points to display the chart.
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...